1. Home
  2. CMPX vs JOF Comparison

CMPX vs JOF Comparison

Compare CMPX & JOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMPX
  • JOF
  • Stock Information
  • Founded
  • CMPX 2014
  • JOF 1990
  • Country
  • CMPX United States
  • JOF Japan
  • Employees
  • CMPX N/A
  • JOF N/A
  • Industry
  • CMPX Biotechnology: Pharmaceutical Preparations
  • JOF Trusts Except Educational Religious and Charitable
  • Sector
  • CMPX Health Care
  • JOF Finance
  • Exchange
  • CMPX Nasdaq
  • JOF Nasdaq
  • Market Cap
  • CMPX 214.6M
  • JOF 220.2M
  • IPO Year
  • CMPX N/A
  • JOF N/A
  • Fundamental
  • Price
  • CMPX $2.92
  • JOF $7.96
  • Analyst Decision
  • CMPX Strong Buy
  • JOF
  • Analyst Count
  • CMPX 6
  • JOF 0
  • Target Price
  • CMPX $12.50
  • JOF N/A
  • AVG Volume (30 Days)
  • CMPX 1.4M
  • JOF 43.9K
  • Earning Date
  • CMPX 03-20-2025
  • JOF 01-01-0001
  • Dividend Yield
  • CMPX N/A
  • JOF 3.33%
  • EPS Growth
  • CMPX N/A
  • JOF N/A
  • EPS
  • CMPX N/A
  • JOF N/A
  • Revenue
  • CMPX $850,000.00
  • JOF N/A
  • Revenue This Year
  • CMPX N/A
  • JOF N/A
  • Revenue Next Year
  • CMPX $613.39
  • JOF N/A
  • P/E Ratio
  • CMPX N/A
  • JOF N/A
  • Revenue Growth
  • CMPX N/A
  • JOF N/A
  • 52 Week Low
  • CMPX $0.77
  • JOF $6.64
  • 52 Week High
  • CMPX $4.08
  • JOF $8.04
  • Technical
  • Relative Strength Index (RSI)
  • CMPX 48.30
  • JOF 59.04
  • Support Level
  • CMPX $3.14
  • JOF $7.89
  • Resistance Level
  • CMPX $3.85
  • JOF $8.01
  • Average True Range (ATR)
  • CMPX 0.33
  • JOF 0.10
  • MACD
  • CMPX -0.11
  • JOF 0.01
  • Stochastic Oscillator
  • CMPX 5.68
  • JOF 84.00

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.

About JOF Japan Smaller Capitalization Fund Inc

Japan Smaller Capitalization Fund Inc is a United States-based non-diversified, closed-end management investment company. Its investment objective is to seek long-term capital appreciation through investments in smaller capitalization Japanese equity securities. Its portfolio of investments consists of different sectors such as banks, chemicals, construction, electric appliances, financing business, food, Information and Communication, Utilities, Real Estate, and others.

Share on Social Networks: